BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/23/2019 6:56:02 AM | Browse: 814 | Download: 1531
Publication Name World Journal of Gastroenterology
Manuscript ID 46670
Country China
Received
2019-03-06 07:06
Peer-Review Started
2019-03-06 08:09
First Decision by Editorial Office Director
2019-04-16 14:39
Return for Revision
2019-04-17 02:37
Revised
2019-04-28 12:14
Publication Fee Transferred
Second Decision by Editor
2019-05-17 08:55
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2019-05-18 12:47
Articles in Press
2019-05-18 12:47
Edit the Manuscript by Language Editor
2019-05-29 20:03
Typeset the Manuscript
2019-07-04 07:13
Publish the Manuscript Online
2019-07-06 06:23
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Manuscript Source Invited Manuscript
All Author List Yu Jiang, Qiu-Ju Han and Jian Zhang
Funding Agency and Grant Number
Corresponding Author Jian Zhang, PhD, Professor, Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, 44 Wenhua West Road, Jinan 250012, Shandong Province, China. zhangj65@sdu.edu.cn
Key Words Hepatocellular carcinoma; Mechanisms; Immunotherapy
Core Tip Among all primary liver cancers, hepatocellular carcinoma (HCC) is the most common and accounts for 90% of cases. Mechanisms related to HCC progression and treatment strategies have been extensively reported. In this paper, we reviewed the molecular mechanisms involved in the progression of HCC and the latest advancements in immunotherapy by combining the research progress and results from our laboratory in recent years.
Publish Date 2019-07-06 06:23
Citation Jiang Y, Han QJ, Zhang J. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy. World J Gastroenterol 2019; 25(25): 3151-3167
URL https://www.wjgnet.com/1007-9327/full/v25/i25/3151.htm
DOI https://dx.doi.org/10.3748/wjg.v25.i25.3151
Full Article (PDF) WJG-25-3151.pdf
Full Article (Word) WJG-25-3151.docx